Foghorn Therapeutics (FHTX) Cash from Operations Growth (1y) (2020 - 2026)
Foghorn Therapeutics (FHTX) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 356.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | -5.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.42% |
| Dec 31, 2025 | 9.17% |
| Sep 30, 2025 | 10.21% |
| Jun 30, 2025 | 17.77% |
| Mar 31, 2025 | 18.32% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | 22.80% |
| Jun 30, 2024 | 20.63% |
| Mar 31, 2024 | 5.89% |
| Dec 31, 2023 | 4.78% |
| Sep 30, 2023 | -36.15% |
| Jun 30, 2023 | -10.90% |
| Mar 31, 2023 | -111.48% |
| Dec 31, 2022 | -343.43% |
| Sep 30, 2022 | 2.52% |
| Jun 30, 2022 | -56.97% |
| Mar 31, 2022 | 1,273.09% |
| Dec 31, 2021 | 211.52% |
| Sep 30, 2021 | -852.09% |
| Jun 30, 2021 | -46.75% |